Kezar Life Sciences Ownership 2024 | Who Owns Kezar Life Sciences Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

61.66%

Insider Ownership

14.84%

Retail Ownership

23.50%

Institutional Holders

85.00

Kezar Life Sciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUVRETTA CAPITAL MANAGEMENT, LLC9.88%0.24%7,167,591--6,462,300Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP6.93%0.15%5,026,0005460.01%4,531,442Mar 31, 2024
BLACKROCK INC.6.36%0.00%4,616,988-200,278-4.16%4,162,677Mar 31, 2024
VANGUARD GROUP INC4.26%0.00%3,094,22430,7401.00%2,789,753Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.2.83%0.26%2,051,676--1,849,791Mar 31, 2024
ORBIMED ADVISORS LLC2.66%0.03%1,927,000--1,737,383Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC2.47%0.01%1,790,838534,20342.51%1,613,000Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC2.43%0.20%1,761,7781,761,778100.00%1,588,419Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.89%0.00%1,373,68919,0411.41%1,238,643Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC1.84%0.00%1,338,07446,1553.57%1,206,000Mar 31, 2024
TWO SIGMA INVESTMENTS, LP1.79%0.00%1,302,25486,0077.07%1,174,112Mar 31, 2024
TWO SIGMA ADVISERS, LP1.70%0.00%1,231,800-90,500-6.84%1,110,591Mar 31, 2024
STATE STREET CORP1.55%-1,123,7747,7220.69%1,013,195Mar 31, 2024
PROSIGHT MANAGEMENT, LP1.33%0.24%963,598-2,401,735-71.37%868,780Mar 31, 2024
IKARIAN CAPITAL, LLC1.20%0.09%868,99215,6011.83%783,484Mar 31, 2024
QIMING U.S. VENTURES MANAGEMENT, LLC1.14%0.83%828,711--747,166Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.13%0.00%816,973-2,110,590-72.09%736,583Mar 31, 2024
ACUITAS INVESTMENTS, LLC0.95%0.31%690,829690,829100.00%622,851Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC0.95%0.06%688,943382,278124.66%621,151Mar 31, 2024
NORTHERN TRUST CORP0.71%0.00%515,363-28,103-5.17%464,651Mar 31, 2024

Kezar Life Sciences's largest institutional shareholder is SUVRETTA CAPITAL MANAGEMENT, LLC, holding 9.88% of the company's total share outstanding, currently valued at $6.46M. The top 10 institutional shareholders own together 41.55% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
QIMING U.S. VENTURES MANAGEMENT, LLC1.14%0.83%828,711--747,166Mar 31, 2024
ACUITAS INVESTMENTS, LLC0.95%0.31%690,829690,829100.00%622,851Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.2.83%0.26%2,051,676--1,849,791Mar 31, 2024
PROSIGHT MANAGEMENT, LP1.33%0.24%963,598-2,401,735-71.37%868,780Mar 31, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC9.88%0.24%7,167,591--6,462,300Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC2.43%0.20%1,761,7781,761,778100.00%1,588,419Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP6.93%0.15%5,026,0005460.01%4,531,442Mar 31, 2024
IKARIAN CAPITAL, LLC1.20%0.09%868,99215,6011.83%783,484Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC0.95%0.06%688,943382,278124.66%621,151Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.33%0.05%236,623236,623100.00%213,339Mar 31, 2024
ORBIMED ADVISORS LLC2.66%0.03%1,927,000--1,737,383Mar 31, 2024
GSA CAPITAL PARTNERS LLP0.39%0.02%282,59522,1888.52%255,000Mar 31, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.17%0.02%126,095126,095100.00%113,688Mar 31, 2024
IRONWOOD INVESTMENT MANAGEMENT LLC0.04%0.01%28,0122,86411.39%25,256Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC2.47%0.01%1,790,838534,20342.51%1,613,000Mar 31, 2024
RETIREMENT CAPITAL STRATEGIES0.02%0.01%15,000--13,524Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP0.04%0.01%31,769-2,525-7.36%28,643Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC0.14%0.00%100,801100,801100.00%90,882Mar 31, 2024
ATOM INVESTORS LP0.03%0.00%25,14925,149100.00%22,674Mar 31, 2024
FIDELIS CAPITAL PARTNERS, LLC0.04%0.00%27,26627,266100.00%24,583Mar 31, 2024

The largest Kezar Life Sciences shareholder by % of total assets is QIMING U.S. VENTURES MANAGEMENT, LLC. The company owns 828.71K shares of Kezar Life Sciences (KZR), representing 0.83% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AFFINITY ASSET ADVISORS, LLC2.43%0.20%1,761,7781,761,778100.00%1,588,419Mar 31, 2024
ACUITAS INVESTMENTS, LLC0.95%0.31%690,829690,829100.00%622,851Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC2.47%0.01%1,790,838534,20342.51%1,613,000Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC0.95%0.06%688,943382,278124.66%621,151Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.33%0.05%236,623236,623100.00%213,339Mar 31, 2024
PANAGORA ASSET MANAGEMENT INC0.32%0.00%233,206149,119177.34%210,259Mar 31, 2024
CITADEL ADVISORS LLC0.70%0.00%509,564144,23539.48%459,423Mar 31, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.17%0.02%126,095126,095100.00%113,688Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC0.14%0.00%100,801100,801100.00%90,882Mar 31, 2024
TWO SIGMA INVESTMENTS, LP1.79%0.00%1,302,25486,0077.07%1,174,112Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC0.38%0.00%273,43071,54335.44%246,524Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.07%-53,31653,316100.00%48,070Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC1.84%0.00%1,338,07446,1553.57%1,206,000Mar 31, 2024
D. E. SHAW & CO., INC.0.58%0.00%419,42542,44911.26%378,153Mar 31, 2024
VANGUARD GROUP INC4.26%0.00%3,094,22430,7401.00%2,789,753Mar 31, 2024
FIDELIS CAPITAL PARTNERS, LLC0.04%0.00%27,26627,266100.00%24,583Mar 31, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.0.04%0.00%26,19526,195100.00%84,086Mar 31, 2024
ATOM INVESTORS LP0.03%0.00%25,14925,149100.00%22,674Mar 31, 2024
UBS GROUP AG0.10%-71,50922,33545.42%64,501Mar 31, 2024
GSA CAPITAL PARTNERS LLP0.39%0.02%282,59522,1888.52%255,000Mar 31, 2024

As of Mar 31 2024, Kezar Life Sciences's largest institutional buyer is AFFINITY ASSET ADVISORS, LLC. The company purchased 1.76M stocks of KZR, valued at $1.59M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PROSIGHT MANAGEMENT, LP1.33%0.24%963,598-2,401,735-71.37%868,780Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.13%0.00%816,973-2,110,590-72.09%736,583Mar 31, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC----1,906,175-100.00%-Mar 31, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.07%0.00%53,216-917,619-94.52%47,980Mar 31, 2024
ANSON FUNDS MANAGEMENT LP----611,249-100.00%-Mar 31, 2024
BLACKROCK INC.6.36%0.00%4,616,988-200,278-4.16%4,162,677Mar 31, 2024
SQUAREPOINT OPS LLC----186,705-100.00%-Mar 31, 2024
MORGAN STANLEY0.14%-101,151-158,132-60.99%91,198Mar 31, 2024
HRT FINANCIAL LP----103,785-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC0.00%-2,600-97,800-97.41%2,344Mar 31, 2024
TWO SIGMA ADVISERS, LP1.70%0.00%1,231,800-90,500-6.84%1,110,591Mar 31, 2024
PALE FIRE CAPITAL SE----68,851-100.00%-Mar 31, 2024
ENGINEERS GATE MANAGER LP----56,826-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/0.05%-33,249-55,992-62.74%29,958,000Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.15%0.00%108,600-50,000-31.53%97,914Mar 31, 2024
BARCLAYS PLC0.07%-50,118-47,919-48.88%45,000Mar 31, 2024
JANE STREET GROUP, LLC0.03%-24,569-44,863-64.61%22,151Mar 31, 2024
GOLDMAN SACHS GROUP INC0.56%0.00%404,706-38,015-8.59%364,883Mar 31, 2024
NORTHERN TRUST CORP0.71%0.00%515,363-28,103-5.17%464,651Mar 31, 2024
XTX TOPCO LTD0.02%0.00%16,723-27,296-62.01%15,077Mar 31, 2024

As of Mar 31 2024, Kezar Life Sciences's biggest institutional seller is PROSIGHT MANAGEMENT, LP. The company sold -2.40M shares of KZR, valued at $868.78K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AFFINITY ASSET ADVISORS, LLC2.43%0.20%1,761,7781,761,778100.00%1,588,419Mar 31, 2024
ACUITAS INVESTMENTS, LLC0.95%0.31%690,829690,829100.00%622,851Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.33%0.05%236,623236,623100.00%213,339Mar 31, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.17%0.02%126,095126,095100.00%113,688Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC0.14%0.00%100,801100,801100.00%90,882Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.07%-53,31653,316100.00%48,070Mar 31, 2024
FIDELIS CAPITAL PARTNERS, LLC0.04%0.00%27,26627,266100.00%24,583Mar 31, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.0.04%0.00%26,19526,195100.00%84,086Mar 31, 2024
ATOM INVESTORS LP0.03%0.00%25,14925,149100.00%22,674Mar 31, 2024
AQR CAPITAL MANAGEMENT LLC0.03%-21,43621,436100.00%19,327Mar 31, 2024
FIRST BANK & TRUST0.02%0.00%11,73911,739100.00%10,584Mar 31, 2024
AVANTAX ADVISORY SERVICES, INC.0.02%0.00%11,11011,110100.00%10,017Mar 31, 2024
CAPITAL ADVISORS, LTD. LLC0.00%0.00%1,6081,608100.00%1,000Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.00%-1,0001,000100.00%920,000Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--1313100.00%11Mar 31, 2024

Kezar Life Sciences's largest new institutional shareholder by number of shares is AFFINITY ASSET ADVISORS, LLC, purchased 1.76M shares, valued at $1.59M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GRANAHAN INVESTMENT MANAGEMENT, LLC----1,906,175-100.00%-Mar 31, 2024
ANSON FUNDS MANAGEMENT LP----611,249-100.00%-Mar 31, 2024
SQUAREPOINT OPS LLC----186,705-100.00%-Mar 31, 2024
HRT FINANCIAL LP----103,785-100.00%-Mar 31, 2024
PALE FIRE CAPITAL SE----68,851-100.00%-Mar 31, 2024
ENGINEERS GATE MANAGER LP----56,826-100.00%-Mar 31, 2024
RVW WEALTH, LLC----23,765-100.00%-Mar 31, 2024
WEXFORD CAPITAL LP----23,320-100.00%-Mar 31, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM----11,747-100.00%-Mar 31, 2024
SIMPLEX TRADING, LLC----3,430-100.00%-Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----194-100.00%-Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.----187-100.00%-Mar 31, 2024

Kezar Life Sciences's largest sold out institutional shareholder by shares sold is GRANAHAN INVESTMENT MANAGEMENT, LLC, sold -1.91M shares, valued at -, as of undefined.

Kezar Life Sciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Manager Directed Portfolios3.66%600,079--Jan 31, 2024
ALGER FUNDS0.19%184,619--Jan 31, 2024
VICTORY VARIABLE INSURANCE FUNDS0.13%63,930--Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS0.08%37,867--Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.08%638,139--Jan 31, 2024
BRIDGEWAY FUNDS INC0.06%147,000-151,500-50.75%Dec 29, 2023
FORUM FUNDS II0.04%39,640--Jan 31, 2024
VICTORY PORTFOLIOS0.03%1,013,406--Dec 31, 2023
IndexIQ ETF Trust0.03%71,027--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.03%11,179--Dec 31, 2023
BNY Mellon Strategic Funds, Inc.0.02%49,096--Mar 31, 2024
Humankind Benefit Corp0.02%456--Dec 31, 2023
Federated Hermes MDT Series0.02%46,568--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.02%122,594--Dec 31, 2023
NEW COVENANT FUNDS0.01%45,653--Dec 31, 2023
ETFis Series Trust I0.01%14,036--Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.01%96,456--Dec 31, 2023
VANGUARD INDEX FUNDS0.01%3,407,015764,73028.94%Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.01%1,311--Dec 31, 2023
ALPS ETF Trust0.00%51,347--Feb 29, 2024
Nushares ETF Trust0.00%29,822--Jan 31, 2024
FIDELITY CAPITAL TRUST0.00%40,264--Jan 31, 2024
Fidelity Commonwealth Trust II0.00%23,776--Aug 31, 2023
INVESCO EXCHANGE-TRADED FUND TRUST0.00%266,288--Jan 31, 2024
FIDELITY SECURITIES FUND0.00%237,620--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%506,95848,28510.53%Feb 29, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%9,109--Dec 31, 2023
Calvert Variable Products, Inc.0.00%4,127--Dec 31, 2023
Direxion Shares ETF Trust0.00%254,558--Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%43,585--Dec 31, 2023
AdvisorShares Trust0.00%3,601--Dec 29, 2023
Principal Exchange-Traded Funds0.00%14,867-2,286-13.33%Mar 31, 2024
FIDELITY ADVISOR SERIES I0.00%214,500--Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%29,376--Dec 31, 2023
GOLDMAN SACHS TRUST0.00%142,219--Feb 29, 2024
TARGET PORTFOLIO TRUST0.00%16,400--Jan 31, 2024
Meeder Funds0.00%3,789--Mar 31, 2024
GPS Funds I0.00%3,139--Dec 31, 2023
Victory Portfolios II0.00%35,136--Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%2,657--Dec 31, 2023
SunAmerica Specialty Series0.00%258--Apr 30, 2021
JPMORGAN TRUST II0.00%464,438--Feb 29, 2024
HC CAPITAL TRUST0.00%14,080--Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.00%27,452--Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%1,049--Dec 31, 2023
AMERICAN CENTURY ETF TRUST0.00%40,954--Feb 29, 2024
OLD WESTBURY FUNDS INC0.00%46,803--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%22,030--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%2,739-1,438-34.43%Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%3,636--Feb 29, 2024
RUSSELL INVESTMENT CO0.00%57,644--Jan 31, 2024
RUSSELL INVESTMENT FUNDS0.00%11,883--Dec 31, 2023
EQ ADVISORS TRUST0.00%207,567-10,793-4.94%Dec 31, 2023
iSHARES TRUST0.00%2,709,856--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%313,42039,28914.33%Feb 29, 2024
RYDEX SERIES FUNDS0.00%652--Dec 31, 2023
Blackstone Alternative Investment Funds0.00%15,9005,90059.00%Dec 31, 2023
ProFunds0.00%1,01741769.50%Jan 31, 2024
VALIC Co I0.00%27,388-110-0.40%Feb 29, 2024
SPDR SERIES TRUST0.00%3,367,391--Dec 31, 2023
RYDEX DYNAMIC FUNDS0.00%323--Dec 31, 2023
NATIONWIDE VARIABLE INSURANCE TRUST0.00%10,798-37,373-77.58%Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%8,576-76-0.88%Jan 31, 2024
PENN SERIES FUNDS INC0.00%1,800--Dec 29, 2023
PGIM ETF TRUST0.00%3,761--Feb 29, 2024
VANGUARD WELLINGTON FUND0.00%20,187--Feb 29, 2024
Dimensional ETF Trust0.00%20,529--Jan 31, 2024
NORTHERN FUNDS0.00%41,476--Dec 29, 2023
PROSHARES TRUST0.00%10,457-3,203-23.45%Feb 29, 2024
RYDEX VARIABLE TRUST0.00%43--Dec 31, 2023
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%8,053--Feb 29, 2024
MASTER INVESTMENT PORTFOLIO0.00%3,133--Dec 31, 2023
Guggenheim Active Allocation Fund0.00%219--Feb 29, 2024
ALLSPRING MASTER TRUST0.00%2,244--Feb 29, 2024
GMO TRUST0.00%46,719--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%59,700--Dec 31, 2023
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%1,356--Dec 31, 2023
ADVANCED SERIES TRUST0.00%102,858--Dec 29, 2023
SUNAMERICA SERIES TRUST0.00%8,085-33-0.41%Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,957--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%18,676--Dec 31, 2023
VANGUARD WORLD FUND0.00%3,512--Feb 29, 2024
Brighthouse Funds Trust I0.00%128,150--Dec 31, 2023
Brighthouse Funds Trust II0.00%24,216--Dec 31, 2023
SEI INSTITUTIONAL MANAGED TRUST0.00%30,442--Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%9,465--Jan 31, 2024
Goldman Sachs Trust II0.00%52,810--Jan 31, 2024
iShares U.S. ETF Trust0.00%1,030--Jan 31, 2024
BLACKROCK FUNDS0.00%61,112--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%17,702-994-5.32%Dec 31, 2023
PACIFIC SELECT FUND0.00%27,659-3,015-9.83%Dec 31, 2023
Advisors' Inner Circle Fund III0.00%114--Jan 31, 2024
WILSHIRE MUTUAL FUNDS INC0.00%1,650--Dec 31, 2023
Bridge Builder Trust0.00%29,756--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%3,026--Dec 31, 2023
FIRST TRUST EXCHANGE-TRADED FUND VIII0.00%256--Feb 29, 2024
BlackRock Variable Series Funds, Inc.0.00%9,437--Dec 31, 2023
Fidelity Rutland Square Trust II0.00%1,6001,600-Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%7,900--Feb 29, 2024
John Hancock Funds II0.00%4,183--Feb 29, 2024

Kezar Life Sciences's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 600.08K shares, compromising 3.66% of its total assets.

Kezar Life Sciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24853.66%
31 Dec, 2382-5.75%
30 Sep, 2387-20.91%
30 Jun, 23110-21.99%
31 Mar, 2314115.57%
31 Dec, 22122-8.96%
30 Sep, 22134-1.47%
30 Jun, 221367.94%
31 Mar, 2212613.51%
31 Dec, 2111142.31%
30 Sep, 21786.85%
30 Jun, 2173-12.05%
31 Mar, 218310.67%
31 Dec, 2075-2.60%
30 Sep, 2077-7.23%
30 Jun, 208343.10%
31 Mar, 20585.45%
31 Dec, 19551.85%
30 Sep, 19543.85%
30 Jun, 19524.00%
31 Mar, 195025.00%
31 Dec, 18408.11%
30 Sep, 183737.04%
30 Jun, 1827-

As of 31 Mar 24, 85 institutions are holding Kezar Life Sciences's shares, representing an increase of 3.66% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2444,737,705-9.25%
31 Dec, 2349,298,586-11.06%
30 Sep, 2355,427,679-2.39%
30 Jun, 2356,787,539-5.14%
31 Mar, 2359,865,7584.58%
31 Dec, 2257,241,950-0.20%
30 Sep, 2257,356,4084.80%
30 Jun, 2254,729,43824.32%
31 Mar, 2244,021,3349.42%
31 Dec, 2140,230,12543.31%
30 Sep, 2128,072,7321.55%
30 Jun, 2127,644,0393.18%
31 Mar, 2126,791,48513.90%
31 Dec, 2023,522,4541.56%
30 Sep, 2023,160,9740.26%
30 Jun, 2023,099,92525.00%
31 Mar, 2018,480,372101.45%
31 Dec, 199,173,566-2.67%
30 Sep, 199,425,080-5.84%
30 Jun, 1910,009,5110.95%
31 Mar, 199,915,0746.18%
31 Dec, 189,337,6613.13%
30 Sep, 189,054,01910.92%
30 Jun, 188,162,306-

Kezar Life Sciences (KZR) has 44.74M shares outstanding as of 31 Mar 24, down -9.25% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2461.66%1.34%
31 Dec, 2367.83%1.16%
30 Sep, 2376.49%1.24%
30 Jun, 2378.51%1.15%
31 Mar, 2382.77%1.32%
31 Dec, 2279.25%1.25%
30 Sep, 2279.49%1.10%
30 Jun, 2285.14%1.62%
31 Mar, 2272.61%1.25%
31 Dec, 2176.25%2.62%
30 Sep, 2153.94%1.90%
30 Jun, 2153.26%1.93%
31 Mar, 2152.47%2.38%
31 Dec, 2046.97%2.19%
30 Sep, 2046.32%1.60%
30 Jun, 2053.80%1.70%
31 Mar, 2056.23%2.43%
31 Dec, 1948.07%1.97%
30 Sep, 1949.36%1.79%
30 Jun, 1952.48%1.94%
31 Mar, 1952.07%2.16%
31 Dec, 1849.13%2.16%
30 Sep, 1847.64%2.58%
30 Jun, 1842.95%-

As of 31 Mar 24, Kezar Life Sciences is held by 61.66% institutional shareholders, representing a 1.34% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2438-5.00%
31 Dec, 23402.56%
30 Sep, 2339-27.78%
30 Jun, 2354-34.15%
31 Mar, 238230.16%
31 Dec, 2263-25.88%
30 Sep, 22857.59%
30 Jun, 227914.49%
31 Mar, 2269-2.82%
31 Dec, 217182.05%
30 Sep, 213914.71%
30 Jun, 2134-5.56%
31 Mar, 2136-7.69%
31 Dec, 20395.41%
30 Sep, 2037-33.93%
30 Jun, 205640.00%
31 Mar, 204029.03%
31 Dec, 1931-6.06%
30 Sep, 1933-13.16%
30 Jun, 1938-7.32%
31 Mar, 194164.00%
31 Dec, 1825-
30 Sep, 1825-7.41%
30 Jun, 1827-

38 institutional shareholders have increased their position in KZR stock as of 31 Mar 24 compared to 40 in the previous quarter (a -5.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 24273.85%
31 Dec, 2326-16.13%
30 Sep, 2331-6.06%
30 Jun, 2333-15.38%
31 Mar, 2339-4.88%
31 Dec, 224141.38%
30 Sep, 2229-14.71%
30 Jun, 2234-17.07%
31 Mar, 224178.26%
31 Dec, 2123-
30 Sep, 2123-11.54%
30 Jun, 2126-16.13%
31 Mar, 213134.78%
31 Dec, 2023-17.86%
30 Sep, 202847.37%
30 Jun, 201918.75%
31 Mar, 20166.67%
31 Dec, 191566.67%
30 Sep, 19912.50%
30 Jun, 19833.33%
31 Mar, 196-33.33%
31 Dec, 18912.50%
30 Sep, 188-
30 Jun, 18--

27 institutional shareholders have reduced their position in KZR stock as of 31 Mar 24 compared to 26 in the previous quarter (a 3.85% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24853.66%44,737,705-9.25%61.66%1.34%38-5.00%273.85%
31 Dec, 2382-5.75%49,298,586-11.06%67.83%1.16%402.56%26-16.13%
30 Sep, 2387-20.91%55,427,679-2.39%76.49%1.24%39-27.78%31-6.06%
30 Jun, 23110-21.99%56,787,539-5.14%78.51%1.15%54-34.15%33-15.38%
31 Mar, 2314115.57%59,865,7584.58%82.77%1.32%8230.16%39-4.88%
31 Dec, 22122-8.96%57,241,950-0.20%79.25%1.25%63-25.88%4141.38%
30 Sep, 22134-1.47%57,356,4084.80%79.49%1.10%857.59%29-14.71%
30 Jun, 221367.94%54,729,43824.32%85.14%1.62%7914.49%34-17.07%
31 Mar, 2212613.51%44,021,3349.42%72.61%1.25%69-2.82%4178.26%
31 Dec, 2111142.31%40,230,12543.31%76.25%2.62%7182.05%23-
30 Sep, 21786.85%28,072,7321.55%53.94%1.90%3914.71%23-11.54%
30 Jun, 2173-12.05%27,644,0393.18%53.26%1.93%34-5.56%26-16.13%
31 Mar, 218310.67%26,791,48513.90%52.47%2.38%36-7.69%3134.78%
31 Dec, 2075-2.60%23,522,4541.56%46.97%2.19%395.41%23-17.86%
30 Sep, 2077-7.23%23,160,9740.26%46.32%1.60%37-33.93%2847.37%
30 Jun, 208343.10%23,099,92525.00%53.80%1.70%5640.00%1918.75%
31 Mar, 20585.45%18,480,372101.45%56.23%2.43%4029.03%166.67%
31 Dec, 19551.85%9,173,566-2.67%48.07%1.97%31-6.06%1566.67%
30 Sep, 19543.85%9,425,080-5.84%49.36%1.79%33-13.16%912.50%
30 Jun, 19524.00%10,009,5110.95%52.48%1.94%38-7.32%833.33%
31 Mar, 195025.00%9,915,0746.18%52.07%2.16%4164.00%6-33.33%
31 Dec, 18408.11%9,337,6613.13%49.13%2.16%25-912.50%
30 Sep, 183737.04%9,054,01910.92%47.64%2.58%25-7.41%8-
30 Jun, 1827-8,162,306-42.95%-27---

Kezar Life Sciences Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 17, 2024Schiller Mark C.officer Chief Legal OfficerSell---39,695
Jan 17, 2024Schiller Mark C.officer Chief Legal OfficerSell165,000$2.28$376.20K-
Jan 17, 2024Schiller Mark C.officer Chief Legal OfficerSell250,000$0.93$232.50K-
Aug 17, 2023Morningside Venture Investments Ltd10 percent owner-G-GiftSell3,500,000--1,947,993
Jul 26, 2023Wallace Courtneydirector-D-ReturnSell52,000$13.87$721.24K-
Jul 26, 2023Wallace Courtneydirector-D-ReturnSell26,000$4.80$124.80K-
Jul 26, 2023Mordwinkin Nicholas Michaelofficer Chief Business OfficerD-ReturnSell185,000$6.84$1.27M-
Jul 26, 2023Klearman Mickidirector-D-ReturnSell26,000$4.80$124.80K-
Jul 26, 2023Klearman Mickidirector-D-ReturnSell26,000$5.59$145.34K-
Jul 26, 2023Klearman Mickidirector-D-ReturnSell52,000$5.94$308.88K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 17, 2024Schiller Mark C.officer Chief Legal OfficerSell---39,695
Jan 17, 2024Schiller Mark C.officer Chief Legal OfficerSell165,000$2.28$376.20K-
Jan 17, 2024Schiller Mark C.officer Chief Legal OfficerSell250,000$0.93$232.50K-
Jan 09, 2024Belsky Marcofficer Chief Financial OfficerA-AwardBuy295,000$0.93$274.35K295,000
Jan 09, 2024Mordwinkin Nicholas Michaelofficer Chief Business OfficerA-AwardBuy275,000$0.93$255.75K275,000
Nov 09, 2023Kirk Christopher J.director, officer CEOA-AwardBuy875,000$0.84$735.00K875,000
Aug 17, 2023Morningside Venture Investments Ltd10 percent owner-G-GiftSell3,500,000--1,947,993
Jul 26, 2023Wallace Courtneydirector-A-AwardBuy52,000$2.28$118.56K52,000
Jul 26, 2023Wallace Courtneydirector-A-AwardBuy26,000$2.28$59.28K26,000
Jul 26, 2023Wallace Courtneydirector-D-ReturnSell52,000$13.87$721.24K-
Jul 26, 2023Wallace Courtneydirector-D-ReturnSell26,000$4.80$124.80K-
Jul 26, 2023Mordwinkin Nicholas Michaelofficer Chief Business OfficerA-AwardBuy185,000$2.28$421.80K185,000
Jul 26, 2023Mordwinkin Nicholas Michaelofficer Chief Business OfficerA-AwardBuy100,000$2.28$228.00K100,000
Jul 26, 2023Mordwinkin Nicholas Michaelofficer Chief Business OfficerD-ReturnSell185,000$6.84$1.27M-
Jul 26, 2023Klearman Mickidirector-A-AwardBuy52,000$2.28$118.56K52,000
Jul 26, 2023Klearman Mickidirector-A-AwardBuy26,000$2.28$59.28K26,000
Jul 26, 2023Klearman Mickidirector-D-ReturnSell26,000$4.80$124.80K-
Jul 26, 2023Klearman Mickidirector-D-ReturnSell26,000$5.59$145.34K-
Jul 26, 2023Klearman Mickidirector-D-ReturnSell52,000$5.94$308.88K-
Jul 26, 2023Kirk Christopher J.director-A-AwardBuy260,000$2.28$592.80K260,000

The last insider sell of Kezar Life Sciences's stock was made by Schiller Mark C. on Jan 17 2024, selling - shares at - per share (valued at -).

Kezar Life Sciences Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20242366.67%
Q4 20231--
Q3 2023344379.07%
Q2 20236--
Q1 202351631.25%
Q4 20221425.00%
Q3 20221--
Q2 20228--
Q1 202262300.00%
Q4 202121200.00%
Q3 202133100.00%
Q2 20218--
Q1 20215--
Q4 202011100.00%
Q2 20209--
Q1 20201011000.00%
Q4 201941400.00%
Q3 201914--
Q2 20196--
Q1 20195--

2 total buy trades, and 3 total sell trades (buy/sell ratio of 0.67%) were made by Kezar Life Sciences's insiders, as of Q1 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2024---
Q4 2023---
Q3 2023---
Q2 2023---
Q1 2023-16-
Q4 2022-3-
Q3 2022---
Q2 2022---
Q1 202211100.00%
Q4 2021---
Q3 2021---
Q2 2021---
Q1 2021---
Q4 2020---
Q2 20202--
Q1 20206--
Q4 20192--
Q3 201912--
Q2 20191--
Q1 2019---

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Kezar Life Sciences's stocks.

Kezar Life Sciences Peer Ownership


TickerCompany
SRZNSurrozen, Inc.
MLYSMineralys Therapeutics, Inc.
DSGNDesign Therapeutics, Inc.
NKTXNkarta, Inc.
NGMNGM Biopharmaceuticals, Inc.
FHTXFoghorn Therapeutics Inc.
KROSKeros Therapeutics, Inc.
KYMRKymera Therapeutics, Inc.
STOKStoke Therapeutics, Inc.
IPSCCentury Therapeutics, Inc.
HOWLWerewolf Therapeutics, Inc.
NRIXNurix Therapeutics, Inc.
RVMDRevolution Medicines, Inc. Warrant
CGEMCullinan Oncology, Inc.
GLUEMonte Rosa Therapeutics, Inc.
STTKShattuck Labs, Inc.
LRMRLarimar Therapeutics, Inc.
IKNAIkena Oncology, Inc.
LYELLyell Immunopharma, Inc.
BOLTBolt Biotherapeutics, Inc.

KZR Ownership FAQ


Kezar Life Sciences is owned by institutional shareholders (61.66%), insiders (14.84%), and public (23.50%). The largest institutional shareholder of Kezar Life Sciences is SUVRETTA CAPITAL MANAGEMENT, LLC (9.88% of total shares) and the top mutual fund owner is Manager Directed Portfolios (3.66% of total shares).

Kezar Life Sciences's major institutional shareholders are SUVRETTA CAPITAL MANAGEMENT, LLC, AVIDITY PARTNERS MANAGEMENT LP, BLACKROCK INC., VANGUARD GROUP INC, and SPHERA FUNDS MANAGEMENT LTD.. The top five shareholders own together 30.26% of the company's share outstanding.

As of Mar 2024, there are 85 institutional shareholders of Kezar Life Sciences.

SUVRETTA CAPITAL MANAGEMENT, LLC owns 7.17M shares of Kezar Life Sciences, representing 9.88% of the company's total shares outstanding, valued at $6.46M (as of Mar 2024).

As of Mar 2024, AVIDITY PARTNERS MANAGEMENT LP holds 5.03M shares of Kezar Life Sciences (KZR), compromising 6.93% of the company, valued at $4.53M.

BLACKROCK INC is the third largest holder of Kezar Life Sciences. The company owns 4.62M of the company's shares outstanding (worth $4.16M).